vs
Encompass Health Corp（EHC）とMAXIMUS, INC.（MMS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.3B、MAXIMUS, INC.の約1.1倍）。Encompass Health Corpの純利益率が高く（9.5% vs 7.0%、差は2.5%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs -4.1%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-250.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs -0.1%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
MAXIMUS社は米国の政府向けサービス企業で、米国、カナダ、英国などで事業を展開している。メディケイド、メディケア、医療改革、就労支援、学生ローン管理など各種政府プログラムに管理業務や関連サービスを提供する。本社はバージニア州タイソンズに所在し、従業員数3万9600人、2024会計年度の売上高は53億米ドルである。
EHC vs MMS — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.3B |
| 純利益 | $146.1M | $93.9M |
| 粗利率 | — | 23.7% |
| 営業利益率 | 16.7% | 10.9% |
| 純利益率 | 9.5% | 7.0% |
| 売上前年比 | 9.9% | -4.1% |
| 純利益前年比 | 20.8% | 128.0% |
| EPS（希薄化後） | $1.43 | $1.70 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | $146.1M | $93.9M | ||
| Q3 25 | $126.5M | $75.3M | ||
| Q2 25 | $142.1M | $106.0M | ||
| Q1 25 | $151.5M | $96.6M | ||
| Q4 24 | $120.9M | $41.2M | ||
| Q3 24 | $108.2M | $72.5M | ||
| Q2 24 | $114.1M | $89.8M | ||
| Q1 24 | $112.5M | $80.5M |
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 25.3% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.9% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 23.6% |
| Q4 25 | 16.7% | 10.9% | ||
| Q3 25 | 14.9% | 9.3% | ||
| Q2 25 | 16.2% | 12.3% | ||
| Q1 25 | 16.4% | 11.2% | ||
| Q4 24 | 14.3% | 6.2% | ||
| Q3 24 | 13.6% | 8.5% | ||
| Q2 24 | 14.3% | 10.8% | ||
| Q1 24 | 13.6% | 9.5% |
| Q4 25 | 9.5% | 7.0% | ||
| Q3 25 | 8.6% | 5.7% | ||
| Q2 25 | 9.7% | 7.9% | ||
| Q1 25 | 10.4% | 7.1% | ||
| Q4 24 | 8.6% | 2.9% | ||
| Q3 24 | 8.0% | 5.5% | ||
| Q2 24 | 8.8% | 6.8% | ||
| Q1 24 | 8.5% | 6.0% |
| Q4 25 | $1.43 | $1.70 | ||
| Q3 25 | $1.24 | $1.27 | ||
| Q2 25 | $1.39 | $1.86 | ||
| Q1 25 | $1.48 | $1.69 | ||
| Q4 24 | $1.18 | $0.69 | ||
| Q3 24 | $1.06 | $1.18 | ||
| Q2 24 | $1.12 | $1.46 | ||
| Q1 24 | $1.10 | $1.31 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $137.6M |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $1.7B |
| 総資産 | $7.1B | $4.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $137.6M | ||
| Q3 25 | $48.7M | $222.4M | ||
| Q2 25 | $99.1M | $59.8M | ||
| Q1 25 | $95.8M | $108.1M | ||
| Q4 24 | $85.4M | $72.7M | ||
| Q3 24 | $147.8M | $183.1M | ||
| Q2 24 | $154.4M | $102.8M | ||
| Q1 24 | $134.4M | $77.4M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $2.4B | $1.7B | ||
| Q3 25 | $2.4B | $1.7B | ||
| Q2 25 | $2.3B | $1.8B | ||
| Q1 25 | $2.2B | $1.7B | ||
| Q4 24 | $2.1B | $1.6B | ||
| Q3 24 | $2.0B | $1.8B | ||
| Q2 24 | $1.8B | $1.8B | ||
| Q1 24 | $1.7B | $1.8B |
| Q4 25 | $7.1B | $4.2B | ||
| Q3 25 | $6.9B | $4.1B | ||
| Q2 25 | $6.8B | $4.5B | ||
| Q1 25 | $6.6B | $4.2B | ||
| Q4 24 | $6.5B | $4.1B | ||
| Q3 24 | $6.5B | $4.1B | ||
| Q2 24 | $6.4B | $4.0B | ||
| Q1 24 | $6.2B | $4.0B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $-244.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $-250.7M |
| FCFマージンFCF / 売上 | 7.6% | -18.6% |
| 設備投資強度設備投資 / 売上 | 14.8% | 0.5% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | -2.60× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $218.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $-244.4M | ||
| Q3 25 | $270.8M | $649.4M | ||
| Q2 25 | $270.2M | $-182.7M | ||
| Q1 25 | $288.6M | $42.7M | ||
| Q4 24 | $278.8M | $-80.0M | ||
| Q3 24 | $267.8M | $163.8M | ||
| Q2 24 | $217.4M | $199.3M | ||
| Q1 24 | $238.8M | $130.5M |
| Q4 25 | $116.7M | $-250.7M | ||
| Q3 25 | $83.7M | $641.8M | ||
| Q2 25 | $113.3M | $-198.2M | ||
| Q1 25 | $125.5M | $25.5M | ||
| Q4 24 | $80.1M | $-103.0M | ||
| Q3 24 | $120.3M | $131.9M | ||
| Q2 24 | $60.5M | $164.6M | ||
| Q1 24 | $99.4M | $105.2M |
| Q4 25 | 7.6% | -18.6% | ||
| Q3 25 | 5.7% | 48.7% | ||
| Q2 25 | 7.8% | -14.7% | ||
| Q1 25 | 8.6% | 1.9% | ||
| Q4 24 | 5.7% | -7.3% | ||
| Q3 24 | 8.9% | 10.0% | ||
| Q2 24 | 4.6% | 12.5% | ||
| Q1 24 | 7.6% | 7.8% |
| Q4 25 | 14.8% | 0.5% | ||
| Q3 25 | 12.7% | 0.6% | ||
| Q2 25 | 10.8% | 1.1% | ||
| Q1 25 | 11.2% | 1.3% | ||
| Q4 24 | 14.1% | 1.6% | ||
| Q3 24 | 10.9% | 2.4% | ||
| Q2 24 | 12.1% | 2.6% | ||
| Q1 24 | 10.6% | 1.9% |
| Q4 25 | 2.37× | -2.60× | ||
| Q3 25 | 2.14× | 8.63× | ||
| Q2 25 | 1.90× | -1.72× | ||
| Q1 25 | 1.90× | 0.44× | ||
| Q4 24 | 2.31× | -1.94× | ||
| Q3 24 | 2.48× | 2.26× | ||
| Q2 24 | 1.91× | 2.22× | ||
| Q1 24 | 2.12× | 1.62× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
